HTL Biotechnology products

HTL is the world leader in the production of pharmaceutical grade Hyaluronic Acid (hyaluronan) by fermentation. This biopolymer is naturally present in the human body where it plays an essential role in several physiological functions. It has been a key ingredient for many different types of biomaterials, medical devices and pharmaceutical products for several decades, and still has great potential for innovation.

HTL is offering a new source of Chondroitin Sulfate and other derivatives, of non-animal origin. While most Chondroitin Sulfate on the market is of animal origin (bovine, pig, shark, fish, bird), HTL is developing a new source of Chondroitin Sulfate of non-animal origin, using biotechnology.

HTL is developing Heparosan, a promising raw material of non-animal origin forthe design of innovative medical devices. OPENING NEW OPPORTUNITIES FOR MEDICAL DEVICES. Building on the success of Hyaluronic Acid, HTL now brings Heparosan to the market, Heparosan is a naturally occurring biopolymer with a structure and basic functionalities that are very close to those of Hyaluronan, With its own specific characteristics and additional functionalities, Heparosan opens up opportunities for innovation in medical devices, when used alone or in combination with Hyaluronic Acid, other biomaterials or actives,

HTL provides HighlyPolyDeoxyRibonucleotides (HDPR), also known as Integral DNA. HTL provides Integral DNA in injectable grade, suitable for medica applications. HTL extracts this API from a renewable animal resource. The gentle production process of integral DNA is designed to protect the double strand structure of DNA and ensure a very high level of purity. The average molecular weight of the product ranges from 0.1 to 5 MDa. This product is ready for use in the manufacture of injectable finished products.